Common (5-15% of users): Mild injection site reactions, minor digestive changes Uncommon (1-5%): Sleep changes, temporary fatigue, mild headache Rare (under 1%): Dizziness, flushing, mood changes Very Rare: Serious adverse effects rarely reported in community use Theoretical Concerns BPC-157s ability to stimulate angiogenesis (blood vessel formation) raises theoretical questions about its use in individuals with active cancer or high cancer risk
Neural Regeneration Research, 17 (3), 482-487
Combining them can stretch fullness even longer after meals - but it also stacks the risk of nausea, vomiting, constipation, and difficulty stepping doses up
Blocking NNMT can boost NAD productionenhancing cellular energy, improving mitochondrial function, and accelerating the breakdown of fat